24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves in…
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the…
The May 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Amgen shares made a slight gain on Tuesday after it was announced that the FDA approved its treatment of glucocorticoid-induced osteoporosis in men and women at high risk of fracture.
Chris Lange Amgen shares saw a nice bump after the FDA on Thursday approved its preventive treatment of migraine in adults.
The April 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in May.
The April 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and biotech companies reporting their latest quarterly results in the coming week.
Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S. and foreign biotechnology and pharmaceutical companies.
The March 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
